Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus typ 1: impact of weight reduction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F15%3A10314096" target="_blank" >RIV/00216208:11150/15:10314096 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/15:10314096
Result on the web
<a href="http://www.nature.com/nutd/journal/v5/n11/full/nutd201533a.html" target="_blank" >http://www.nature.com/nutd/journal/v5/n11/full/nutd201533a.html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/nutd.2015.33" target="_blank" >10.1038/nutd.2015.33</a>
Alternative languages
Result language
angličtina
Original language name
Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus typ 1: impact of weight reduction
Original language description
Background: Omentin-1 is an anti-inflammatory adipokine produced preferentially by visceral adipose tissue. Plasma levels of omentin-1 are decreased in obesity and other insulin-resistant states. Insulin resistence contributes to the changes of cholesterol synthesis and absorption as well. The aim of this study was to characterise omentin-1 plasma levels in obese patients with diabetes melltius type 1 during weight reduction, and to elucidate the relationship between cholesterol metabolism and omentin-1. Methods: Plasma levels of omentin-1 were measured in obese type 1 diabetics (n=14, body mass index )30 kg m-2, age 29-62 years) by enzyme-linked immunosorbent assay (BioVendor). Gas chromatography with flame ionisation detector (Fisons Plc.,) was usedto measure squalene and non-cholesterol sterols - markers of cholesterol synthesis and absorption (phase I). Measurements were repeated after 1 month (phase II; 1 week of fasting in the hospital setting and 3 weeks on a diet containing 15
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nutrition and Diabetes [online]
ISSN
2044-4052
e-ISSN
—
Volume of the periodical
5
Issue of the periodical within the volume
November
Country of publishing house
GB - UNITED KINGDOM
Number of pages
6
Pages from-to
—
UT code for WoS article
000368900100001
EID of the result in the Scopus database
2-s2.0-84946563175